ACADIA Pharmaceuticals
ACAD
#3825
Rank
HK$19.01 B
Marketcap
HK$113.99
Share price
2.37%
Change (1 day)
-14.38%
Change (1 year)

Earnings for ACADIA Pharmaceuticals (ACAD)

Earnings in 2024 (TTM): HK$2.00 Billion

According to ACADIA Pharmaceuticals's latest financial reports the company's current earnings are HK$0.95 Billion. , an increase over its 2023 earnings that were of -HK$0.4 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for ACADIA Pharmaceuticals from 2003 to 2024

Annual earnings

Year Earnings Change
2024 HK$2.00 B-605.67%
2023 -HK$0.4 Billion-76.09%
2022 -HK$1.66 Billion27.41%
2021 -HK$1.3 Billion-40.38%
2020 -HK$2.19 Billion19.88%
2019 -HK$1.82 Billion-3.92%
2018 -HK$1.9 Billion-15.04%
2017 -HK$2.23 Billion6.33%
2016 -HK$2.1 Billion64.55%
2015 -HK$1.28 Billion77.47%
2014 -HK$0.72 Billion143.69%
2013 -HK$0.3 Billion81.93%
2012 -HK$0.17 Billion-8.73%
2011 -HK$0.18 Billion-251.39%
2010 HK$0.11 B-133.2%
2009 -HK$0.36 Billion-30.82%
2008 -HK$0.51 Billion6.43%
2007 -HK$0.48 Billion25.89%
2006 -HK$0.39 Billion36.99%
2005 -HK$0.28 Billion37.22%
2004 -HK$0.21 Billion19.96%
2003 -HK$0.17 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-HK$0.32 Billion-115.76%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$86.23 B 4,206.11%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$98.39 B 4,813.46%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$135.34 B 6,658.50%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$65.02 Billion-3,346.73%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$0.3 Billion-114.97%๐Ÿ‡บ๐Ÿ‡ธ USA